Appime T 500mg/62.5mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Cefepime (500mg) + Tazobactum (62.5mg)
Overview Appime T 500mg/62.5mg Injection
T-Comb 500mg/62.5mg Injection combines two antibiotics to combat diverse bacterial infections by inhibiting microbial proliferation. Administer this medication solely under a physician's guidance; adhere strictly to the prescribed dosage schedule. Complete the entire course, regardless of symptom improvement. Typical side effects may include nausea, vomiting, diarrhea, and skin rashes; injection site reactions (redness, swelling, pain) are also possible, usually resolving spontaneously. Report any worsening side effects promptly to your doctor. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Disclose all current medications, including those for pre-existing conditions, to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician. Alcohol consumption should be avoided due to the potential for increased drowsiness. While driving ability is generally unaffected, refrain from driving if experiencing somnolence or dizziness.
Uses of Appime T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Appime T 500mg/62.5mg Injection:
Administering this medication will be handled by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Appime T 500mg/62.5mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Appime T 500mg/62.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Appime T 500mg/62.5mg Injection works:
Appime T Injection, containing 500mg Cefepime and 62.5mg Tazobactum, combines an antibiotic with a beta-lactamase inhibitor. Cefepime's antibiotic action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactum counteracts bacterial enzymes (beta-lactamases) that would otherwise neutralize Cefepime. This synergistic effect broadens Cefepime's antibacterial spectrum and overcomes resistance mechanisms.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Appime T 500mg/62.5mg Injection necessitates careful consideration. Medical advice is recommended.
PregnancySAFE IF PRESCRIBED
The injectable medication Appime T 500mg/62.5mg is typically regarded as safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Appime T, 500mg/62.5mg, presents a low risk during lactation. Research in humans indicates minimal drug transfer to breast milk, posing no known threat to the infant.
DrivingUNSAFE
Following administration of Appime T 500mg/62.5mg Injection, temporary blurred vision may occur. Refrain from driving until your vision has returned to normal.
KidneyCAUTION
Individuals with kidney impairment should use the Appime T 500mg/62.5mg Injection with care. Dosage modification for Appime T 500mg/62.5mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Appime T 500mg/62.5mg Injection in patients with liver impairment appears to present a low risk. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Appime T 500mg/62.5mg Injection :
Should you inadvertently omit a scheduled dose of Appime T 500mg/62.5mg Injection, seek medical advice from your physician.
Facts to Know About Appime T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently